Why is Tissue Regenix Group Plc ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -2.01
2
Negative results in Dec 24
- RAW MATERIAL COST(Y) Grown by 11.78% (YoY)
- CASH AND EQV(HY) Lowest at GBP 1.49 MM
- DEBT-EQUITY RATIO (HY) Highest at 28.82 %
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -86.57%, its profits have fallen by -33%
4
Underperformed the market in the last 1 year
- Even though the market (FTSE 100) has generated returns of 20.16% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -86.57% returns
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Tissue Regenix Group Plc for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Tissue Regenix Group Plc
-86.57%
-1.33
67.03%
FTSE 100
16.5%
1.55
12.98%
Quality key factors
Factor
Value
Sales Growth (5y)
9.08%
EBIT Growth (5y)
14.04%
EBIT to Interest (avg)
-2.01
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0.60
Tax Ratio
52.65%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
0.23%
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.39
EV to EBIT
-15.67
EV to EBITDA
15.67
EV to Capital Employed
0.55
EV to Sales
0.78
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1.78%
ROE (Latest)
-5.87%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Bearish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Tissue Regenix Group Plc
Net Profit
Higher at GBP -0.37 MM
than preceding 12 month period ended Dec 2024MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (GBP MM)
Debtors Turnover Ratio
Highest at 6.41%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Tissue Regenix Group Plc
Net Sales
At GBP 9.49 MM has Fallen at -22.8%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (GBP MM)
Net Sales
Lowest at GBP 9.49 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (GBP MM)
Cash and Eqv
Lowest at GBP 1.49 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 28.82 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 11.78% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






